(Q37104814)

English

Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting

scientific article published on May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

(3aS)-palonosetron

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jon D Herrington

1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Adam D Jaskiewicz

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Juhee Song

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

language of work or name

0 references

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

112

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

2080-2087

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

21 January 2018

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III ran

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23364

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23364

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37104814&oldid=2104978115"